

Publisher: Bentham Science Publishers
E-ISSN: 1875-6913|9|1|14-24
ISSN: 1875-6921
Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.9, Iss.1, 2011-03, pp. : 14-24
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Fluconazole effective in cutaneous leishmaniasis
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :




Infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1271, 2009-01 ,pp. :


Adalimumab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. :


Infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1299, 2010-01 ,pp. :